Browse Articles

Discover research articles across all indexed journals

An Absorption‐Transport Reconfigurable 2D/3D/2D Architecture Enables Multispectral‐Adaptive Bifacial Perovskite Photovoltaics

Advanced Materials Siyang Zhang, Haoxuan Sun, Min Wang et al. Jul 01, 2026 DOI: 10.1002/adma.73575

ABSTRACT Tandem architectures have emerged as the prevailing strategy to overcome the fundamental trade‐off between broadband photon absorption and efficient photon‐energy utilization in photovoltaic devices. However, only the complex and implementation‐demanding multi‐terminal tandem configuration offers adaptability to diverse light sources. Here, we introduce an absorption‐transport reconfigurable architecture implemented in a bifacial single‐junction device, which harnesses the previously overlooked parasitic absorption of a 2D perovskite passivation layer to achieve spectral absorption separation between high‐energy blue‐violet and low‐energy green‐to‐near‐infrared photons. This design not only enables efficient bifacial operation with near‐omnidirectional light harvesting but also supports broadly applicable photon‐energy harvesting under both sunlight and artificial lighting. Notably, the V oc under blue‐light illumination reaches 1.67 V, exceeding the V oc ceiling of a 1.55 eV single‐junction absorber. In terms of applicability, a single device can deliver PCEs of 24.69% (AM 1.5G), 38.45% (warm‐white LED), and 37.55% (cool‐white TL84 fluorescent), alongside a record V oc of 1.081 V under weak illumination (1122 lux/346 µW cm −2 ). Owing to the robust interfacial anchoring design, the champion device retains >90% of its initial performance after 2000 h of continuous operation, thereby offering a viable pathway toward rapid, scenario‐agnostic deployment.

Continuous Monitoring of Body Fluid by Flexible Bio‐Integrated Flow Sensors

Advanced Materials Zhiqiang Ma, Deyuan Zhang, Mohd Faizul Mohd Sabri et al. Jul 01, 2026 DOI: 10.1002/adma.202523029

ABSTRACT Body fluids play pivotal roles in maintaining health. Flexible bio‐integrated flow sensor (BIFS) devices and systems overcome the bulky size and intermittent monitoring of conventional clinical equipment. They enable real‐time, continuous monitoring of body fluids, thereby advancing healthcare. However, challenges such as low sensitivity and inadequate stability have hindered their widespread clinical and practical applications. In this review, we present the latest advancements in BIFS for continuous monitoring of human body fluids. Initially, we delineate effective engineering strategies for developing high‐performance BIFS devices and systems, encompassing fundamental working mechanisms, design approaches for microscale functional materials, and methodologies for macroscale fluid‐structure interaction structures. Subsequently, we compile and showcase representative BIFS and their applications in personalized healthcare. Finally, we explore and present potential directions for the development of BIFS for practical and continuous monitoring of human body fluids, offering insights into future perspectives in this domain.

Real-world treatment patterns and survival outcomes in acinic cell carcinoma of the breast: A National Cancer Database study.

Journal of Clinical Oncology Cher Ying Foo, Ojasav Sehrawat, Waqar Haque et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.41

41 Background: Acinic cell carcinoma (ACC) of the breast is a rare subtype characterized by serous acinar differentiation resembling that of salivary gland ACC. Although often classified within the triple-negative breast cancer spectrum, breast ACC has been reported to exhibit relatively favorable outcomes, however evidence is largely limited to case reports and small case series. Methods: The National Cancer Database (NCDB) was queried for patients with invasive ACC of the breast between 2004 to 2023. Baseline demographic, tumor, and treatment characteristics were summarized descriptively. Overall survival (OS) was assessed using Kaplan-Meier analysis and compared with log-rank tests. Multivariable Cox regression analysis was used to evaluate independent associations with OS. Results: A total of 149 patients with breast ACC were identified. The mean age at diagnosis was 57.8 ± 14.3 years, and the median tumor size was 2.0 cm (IQR 1.5–3.0). Median follow-up was 58.3 months (IQR 40.0–116.1), during which 27 deaths occurred. Tumors were frequently high-grade with 44.6% poorly differentiated or anaplastic, and node-positive disease was present in 27.0% of patients. Most patients presented with early-stage disease (Stage I–II, 86.7%). Hormone receptor expression was common (ER 57.1%, PR 50.7%), whereas majority of tumors were HER2 negative (93.5%). Surgical resection was performed in 92.4% patients, with equal utilization of breast-conserving surgery (BCS) and mastectomy (46.2% each). Radiation was administered in 54.5%, chemotherapy in 56.6%, and hormonal therapy in 54.1%, while immunotherapy use was uncommon (12.8%). On survival analysis, older age ( p =0.0001), advanced stage ( p =0.0006), and nodal positivity (p=0.04) were significantly associated with worse OS, whereas receptor status was not associated with OS. Surgical resection was associated with improved survival (p=0.0054), while radiation, chemotherapy and hormonal therapy were not associated with OS. Patients who did not undergo surgical resection had significantly worse survival compared with those treated with either BCS or mastectomy (HR 4.41 and 4.32, respectively; both p <0.01), with no survival difference observed between BCS and mastectomy. On multivariable analysis adjusting for age, tumor size and comorbidity burden, surgical resection remained independently associated with improved survival (HR 0.19, 95% CI 0.04–0.80, p =0.024). Conclusions: In this largest national population-based study to date, breast ACC demonstrated heterogeneous clinicopathologic features including frequent high-grade disease and nodal involvement. Surgical resection was independently associated with improved survival, while systemic therapies were not associated with OS. These findings provide important real-world data to inform clinical management of this rare breast cancer subtype.

Addressing radiologist inter-reader variability in gastric cancer T staging: A prospective study using the dual-module AI model, TRACE.

Journal of Clinical Oncology Chun Yang, Jing Zhang, Yan Zhao et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.102

102 Background: Gastric cancer, a leading global malignancy with high incidence and mortality, poses a significant public health burden in China. Accurate preoperative T Staging, assessing tumor invasion depth via contrast-enhanced computed tomography (CE-CT), is crucial for treatment planning but suffers from inter-observer variability, particularly in T4a versus T4b discrimination. To enhance diagnostic precision and reproducibility, we introduce TRACE (Two-component Radiology-guided Autonomous Cascade Engine), a dual-module deep learning model for automated, nuanced gastric cancer T-staging. Methods: This multicenter study included both retrospective and prospective cohorts. We developed the TRACE model featuring a dynamic cascaded architecture simulating radiologists' stepwise diagnostic process: first, a hybrid CNN and hierarchical Transformer model performed initial T1-T4 screening; if classified as T4, a second specialized ResNet-152 model was automatically triggered for T4a/T4b subclassification. A total of 3,874 patients from three medical centers were enrolled. The two sub-models were trained using 1,652 (T1-T4) and 567 (T4a/T4b) samples from one center, and validated on two retrospective external cohorts (EVC1: n=850; EVC2: n=550) and one prospective cohort (PVC: n=822). Using postoperative pathology as the gold standard, we evaluated discriminative performance (accuracy, macro-averaged AUC), calibration (Brier score), and clinical utility (comparison with radiologists). Results: TRACE demonstrated excellent and robust performance across multiple independent validation cohorts. For the five-class T staging task, the model achieved a macro-averaged AUC of 0.964 (95% CI: 0.951–0.976) with 94.4% accuracy in EVC1, and a macro-averaged AUC of 0.949 with 82.4% accuracy in the prospective cohort. The T4 subclassification model attained accuracies ranging from 86.7% to 96.2% in external validations. Importantly, TRACE assistance significantly improved radiologists' diagnostic performance, increasing average sensitivity from 40.0% to 75.2% and overall accuracy from 41.2% to 79.6%. Grad-CAM analysis revealed that model attention regions aligned with clinically relevant anatomical landmarks. Conclusions: This study successfully developed and multi-center validated TRACE, the first AI system enabling end-to-end prediction covering all five gastric cancer T stages (T1, T2, T3, T4a, T4b). The model demonstrated high accuracy, excellent generalizability, and significant clinical utility, effectively addressing the subjectivity and inconsistency in current CT interpretation. TRACE provides a reliable automated tool for precise preoperative staging and individualized treatment decision-making in gastric cancer.

Polymer-Modulated Solvation Chemistry via Compatibilizing-Solvent Plasticization for Stable High-Energy Lithium Metal Batteries

Journal of the American Chemical Society Ruogu Xu, Yujie Wang, Shengjun Xu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c02800

ST-GNNFormer: coupling dynamic graph learning and multi-scale temporal attention for traffic flow forecasting

Scientific Reports Zhengjia Chen, Junhao Chen Jul 01, 2026 DOI: 10.1038/s41598-026-59250-y

Competitive Solvation‐Driven Interface Stabilization for Protic Deep Eutectic Solid Electrolyte in Sodium‐Metal Batteries

Advanced Materials Xinke Dai, Shuilai Qiu, Mingshuai Wu et al. Jul 01, 2026 DOI: 10.1002/adma.73790

ABSTRACT Solid‐state sodium batteries (SSSBs) are promising for safe and high‐energy storage, while their development is hindered by the low ionic conductivity of solid electrolytes and severe interfacial side reactions, especially when protic deep eutectic electrolytes (DEEs) are employed to enhance conductivity. The active hydrogen in typical DEEs (e.g., N‐methylacetamide, NMA) readily reacts with the sodium metal negative electrode, leading to rapid performance decay. Herein, we propose a solvation reconstruction strategy to address this issue by incorporating polar carbonate ester into a composite solid electrolyte (CSE) based on NaTFSI‐NMA DEE. Carbonate ester molecules preferentially enter the solvation structure of Na + , replacing NMA from the primary solvation sheath layer, thereby inhibiting its interfacial by‐reaction with the Na negative electrode. The optimized electrolyte (PNDC) exhibits a high ionic conductivity of 2.82 mS·cm −1 , a Na + transference number of 0.77, a low activation energy of 0.12 eV, and a wide electrochemical window of 4.8 V. The assembled sodium metal cell can operate stably for 2500 cycles at 5 C. Moreover, it demonstrates excellent safety performance. This work presents a rational solvation engineering approach to overcome the interfacial challenges of protic DEEs, offering a safe and high‐performance electrolyte for fast‐charging SSSBs.

Ultrasensitive Pressure‐Responsive Upconversion Luminescence in Cs <sub>2</sub> NaBiCl <sub>6</sub> :Yb <sup>3+</sup> /Mn <sup>2+</sup> Optical Manometry

Advanced Materials Qianqi Yang, Chenliang Li, Datao Tu et al. Jul 01, 2026 DOI: 10.1002/adma.73505

ABSTRACT Current optical manometers that rely on ultraviolet (UV) excitation suffer from low pressure sensitivity, high cost of UV lasers, and severe photoluminescence interference caused by spectral overlap between the excitation/emission light and background fluorescence. To address these issues, we herein explored a kind of novel optical manometry based on Cs 2 NaBiCl 6 :Yb 3+ /Mn 2+ double perovskite, exhibiting pressure‐sensitive broadband upconversion emission that originated from Yb 3+ ‐Mn 2+ dimers. By virtue of near‐infrared (NIR) energy transfer from Yb 3+ to Yb 3+ ‐Mn 2+ dimers, a linear upconversion pressure sensitivity as high as 15.03 nm/GPa was achieved upon 980‐nm excitation, which is over forty times higher than that of commercial manometer Ruby (0.36 nm/GPa) and traditional lanthanide (Ln 3+ )‐doped upconversion luminescence (UCL) phosphors (∼0.20 nm/GPa). Through in situ pressure‐dependent structural analysis, it was demonstrated that such exceptional pressure‐sensing performance stems from the soft lattice of Cs 2 NaBiCl 6 , which has a significantly low bulk modulus of 23.69 GPa. In addition, the pressure‐dependent Raman spectra further verified the stability and repeatability of Cs 2 NaBiCl 6 :Yb 3+ /Mn 2+ at extreme conditions. This work develops an ultrasensitive pressure‐responsive upconversion luminescent material, establishing a reliable visual optical strategy for high‐precision pressure monitoring in versatile scenarios.

Targeting human neuropeptide Y1 receptor (NPY1R) using a monoclonal antibody that targets an extracellular epitope.

Journal of Clinical Oncology Arezoo Sadeghi Vardanjani, David L. Hare, Peter J. Wookey Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.65

65 Background: Neuropeptide Y1 Receptor (NPY1R), a G protein-coupled receptor, is essential for regulating appetite, energy balance, and emotional responses, and is implicated in pathological disorders like obesity, anxiety and cancers. Currently, only small molecule reagents are available for assessing the expression of NPY1R in cancers. This study provides evidence supporting validation of one monoclonal antibody, mAb2A10, which binds an epitope in extracellular loop 2 of human NPY1R. Methods: The immediate aim was the validation of the monoclonal antibody mAb2A10 using a COS-7 cell line developed to overexpress human NPY1R (clone D9), and comparison with ER-positive MCF-7 breast cancer cells and Jurkat cells using FACS analysis, Western blotting, and confocal microscopy. The FLAG-NPY1R construct was introduced into COS-7 cells via plasmid transfection, followed by successive selection with puromycin to establish stable cell lines. Using flow cytometry, an anti-FLAG:568 antibody was used to identify a high NPY1R-expressing clone, D9. Results: Western blotting identified a ~136 kDa band in the high NPY1R-expressing D9 clone, MCF-7 and Jurkat cells), which was reduced when cells were grown in non-estrogenic media (charcoal stripped phenol red-free media plus FBS), indicating that the estrogenic effect regulates NPY1R at the protein level. The estrogen receptor (ER) exerts a positive effect on the activity of NPY1R; however, it is not yet established whether this affects mRNA expression or protein activation. Confocal microscopy supported these findings by confirming specific cellular localisation of NPY1R in D9 and MCF-7 cells. Conclusions: Therefore, the antibody validation process confirmed the specificity of mAb2A10 for FLAG-NPY1R. These findings collectively support the antibody's potential as a diagnostic or therapeutic tool for identifying NPY1R-expressing cancers including breast cancer.

Molecular classification of biliary tract cancer by RNA clustering analysis and its clinicopathological characteristics.

Journal of Clinical Oncology Yuta Maruki, Kathleen Yasmin de Almeida, Hiroyuki Aburatani et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.143

143 Background: Biliary tract cancer (BTC) is a rare malignancy but occurs more frequently in Asian populations, where the establishment of molecularly guided treatment strategies is of particular importance. Intrahepatic cholangiocarcinoma has been classified into small-duct and large-duct types based on molecular features, each characterized by distinct genetic alterations. However, the clinical significance of RNA expression–based molecular classification in BTC remains unclear. Methods: Patients with BTC enrolled in the multinational MASTER KEY Asia registry, including the CHOICE sub-cohort, who had matched DNA sequencing and RNA expression data by NGS were included. Gene expression profiles from 93 cholangiocarcinoma tumors were analyzed using unsupervised hierarchical clustering to define transcriptomic subgroups, and heatmaps were generated using scaled expression values. Mutation profiles were aligned with clusters, and the top 10 most frequently mutated genes in each group were compared. Clinicopathological features and treatment responses were evaluated across subgroups. Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan–Meier and log-rank tests, with Cox proportional hazards and logistic regression analyses performed to identify prognostic factors and determinants of cluster assignment. Results: Unsupervised clustering identified two major transcriptomic groups, designated CHOL1 (n=61) and CHOL2 (n=32), with distinct gene expression profiles. The median age was significantly lower in CHOL2 compared with CHOL1 (56.3 vs. 62.7 years, p=0.009). In addition, logistic regression analysis demonstrated that younger age and a positive family history of cancer were significantly associated with CHOL2 membership (p=0.013 and p=0.009, respectively). Distinct genetic alteration patterns were identified: KRAS (36.1% vs. 9.4%, p=0.006) and SMAD4 mutations (26.2% vs. 3.1%, p=0.005) were more frequent in CHOL1, whereas FGFR2 fusions (1.6% vs. 9.4%, p=0.11) and IDH1 mutations (0% vs. 15.6%, p=0.003) were numerically more common in CHOL2. In CHOL2, a subset of cases harbored TERT promoter mutations and exhibited gene expression signatures associated with aggressive HCC. However, no significant differences were observed in response rates to systemic therapy, PFS, or OS between clusters. Conclusions: RNA-based molecular classification of BTC identified two distinct clusters with different clinical and genomic characteristics. CHOL2 was associated with younger age and enrichment of actionable alterations such as FGFR2 fusions and IDH1 mutations. Although no differences in treatment efficacy were observed between clusters, heterogeneity in treatment regimens across countries may have limited evaluation, highlighting the need for further validation in homogeneous cohorts. Clinical trial information: NCT05217407 .

A Deep‐Red‐Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death

Angewandte Chemie International Edition Yiyi Zhang, Pierre Mesdom, Eduardo Izquierdo‐García et al. Jul 01, 2026 DOI: 10.1002/anie.8677989

ABSTRACT Immunogenic cell death (ICD), which converts tumor cells into their own vaccine, plays a pivotal role in the development of novel anticancer therapies. Here, a small series of osmium(II) polypyridyl complexes was synthesized, and their biological activity in the dark and upon light irradiation against various cancer cell lines was studied. The compound Os2 (bearing two 4,7‐diphenyl‐1,10‐phenanthrolines and one substituted bipyridine ligand) was discovered to be the most effective photosensitizer (PS) for photodynamic therapy (PDT) of this series through the photogeneration of 1 O 2 and •OH. In addition, Os2 was found to exhibit promising toxicity upon deep‐red irradiation under both normoxia and hypoxia. These observations indicate that this PS is working through a mixture of Type‐I and Type‐II mechanisms. More interestingly, upon 740 nm irradiation, Os2 can stimulate a strong ICD response on CT26 and MCA205 cells both in vitro and in vivo. A comprehensive immune analysis showed that mice vaccinated with Os2 ‐treated CT26‐luc cells boosted the systemic specific adaptive immune responses, including the activation of CD8 + T cells and reprogramming of macrophages, leading to effective inhibition of tumor growth. Os2 is, to the best of our knowledge, the first photoactive osmium‐based complex inducing ICD.

One-year clinical outcomes of implantable collamer lens implantation for myopic regression after laser vision correction

Scientific Reports Ji Youn Choi, Seung Eun Lee, Min Ho Kang et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60431-y

Coordination‐Induced Dispersion of Covalent Organic Frameworks for Organic Solar Cells With 21.03% Efficiency

Advanced Materials Mengdi Li, Chengyi Xiao, Yang Cheng et al. Jul 01, 2026 DOI: 10.1002/adma.73825

ABSTRACT Covalent organic frameworks (COFs) offer modular architectures and ordered π‐channels ideal for organic solar cells (OSCs), yet their integration is hindered by poor solubility and deficient film‐forming rheology. Herein, a coordination‐induced dispersion strategy is reported using vanadium ions to unlock the potential of COFs as high‐performance hole transport layers (HTLs). By intercalating vanadium ions into a novel COF (TBpy), the metal centers act as “molecular wedges,” increasing interlayer spacing to transform the rigid framework into a highly dispersible, solution‐processable precursor. This coordination refines film morphology and fine‐tunes the electronic structure, establishing a seamless cascaded energy alignment. Consequently, OSCs utilizing TBpy‐V HTLs achieve a high power conversion efficiency of 21.03% and extraordinary durability ( T 80 lifetime of 20,097 h). Notably, the high conductivity of the framework renders the device thickness‐insensitive, maintaining 17.80% PCE at 75 nm—a critical advantage for large‐scale manufacturing. This study establishes metal‐ion intercalation as a versatile tool for optimizing both the processability and electronic dynamics of crystalline optoelectronic materials.

Survivorship care planning and psychosocial outcomes in cervical cancer caregivers.

Journal of Clinical Oncology Priyadharshini Mari, Deepak Saini, Abhishek Shankar Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.214

214 Background: Survival in Cervical Cancer has improved substantially, increasing reliance on informal caregivers throughout the survivorship trajectory. Caregivers experience multidimensional burdens, yet quantitative data evaluating their psychosocial distress, access to support services, and awareness of survivorship resources remain limited. This study assessed caregiver experiences using structured statistical analysis. Methods: A cross-sectional study was conducted among 57 caregivers of cervical cancer patients using a structured survivorship questionnaire. Univariate analysis (chi-square/Fisher’s exact test) evaluated associations between caregiver distress and selected variables. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. Results: Mean caregiver age was 42.6 ± 11.3 years; 39/57 (68.4%) were female. Survivorship beginning at diagnosis was agreed upon by 43/57 (75.4%). Survivorship care plans were reported in 18/57 (31.6%). Psychological distress was reported by 41/57 (71.9%) for fear of recurrence, 38/57 (66.7%) for anxiety/depression, 36/57 (63.2%) for stress, and 29/57 (50.9%) for isolation. Income reduction occurred in 32/57 (56.1%). Support services were offered to 22/57 (38.6%). Lack of support was associated with higher distress (85.7% vs. 54.5%; OR 4.96, 95% CI 1.38–17.76; p = 0.01). Income reduction correlated with increased stress (81.3% vs. 48.0%; OR 4.61, 95% CI 1.29–16.39; p = 0.02). Absence of a survivorship care plan was associated with greater fear/uncertainty (83.8% vs. 55.6%; OR 4.02, 95% CI 1.12–14.39; p = 0.03). Clinical trial participation was 11/57 (19.3%); non-offer rate 37/57 (64.9%). Conclusions: Caregiver distress was significantly associated with lack of structured support, income reduction, and absence of survivorship care planning.

Comparative effectiveness of different interventions in metastatic melanoma: A network meta-analysis.

Journal of Clinical Oncology Sami Salahia Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.294

294 Background: Multiple therapeutic options are available for metastatic melanoma, including immune checkpoint inhibitors (ICIs) and BRAF/MEK-targeted therapies, yet optimal treatment selection remains unclear. Methods: We conducted a network meta-analysis synthesizing randomized controlled trials examining metastatic melanoma treatment efficacy. Primary outcomes included overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and adverse events. Network meta-analyses estimated hazard ratios and odds ratios with 95% confidence intervals. Results: Combination nivolumab plus ipilimumab achieved five-year OS of 55.7% with 52.2% response rates versus 34.3% OS and 31.6% response with monotherapy. Pembrolizumab monotherapy showed median OS of 32.7 months versus 15.9 months with ipilimumab. Combined BRAF-MEK inhibition significantly improved PFS (HR: 0.58 versus BRAF alone) and OS (HR: 0.67) compared with monotherapy. Triple therapy combining targeted therapy with immunotherapy demonstrated longer PFS than BRAF/MEK alone (HR: 0.76) but with increased adverse events. Immune-related adverse events occurred in 93.2% with combination immunotherapy versus 81.9% with monotherapy. In specialized populations, uveal melanoma patients achieved superior outcomes with dual immunotherapy (12.4% objective response, 16.3-month OS) versus monotherapy (3.4% response, 9.8-month OS). Acral melanoma patients showed worse prognosis (15-month median OS) but demonstrated anti-PD-1 superiority over anti-CTLA-4 (53% versus 34% one-year survival). Conclusions: Combination immunotherapy provides greatest efficacy with higher toxicity; BRAF/MEK inhibitors offer rapid disease control. Immunotherapy is preferred first-line treatment for most patients regardless of BRAF status [7]. Optimal outcomes require individualized selection based on mutation status, disease burden, and patient factors.

Ultrahigh‐Efficiency and Long‐Calendar‐Life Aqueous Cadmium Metal Batteries Under Extremely Harsh Conditions

Angewandte Chemie International Edition Songyang Chang, Wentao Hou, Linguo Lu et al. Jul 01, 2026 DOI: 10.1002/anie.9382429

ABSTRACT Aqueous multivalent metal batteries (AMMBs) hold great promise for non‐flammable, cost‐effective, and scalable energy storage. However, the parasitic hydrogen evolution reaction (HER) has severely plagued the metal plating efficiency and calendar life, particularly under realistic stress conditions, including low current densities, extended storage periods, and harsh temperatures. Herein, we leverage the inherent HER resistance of cadmium metal and the water‐confining solvation structures of concentrated electrolytes to synergistically tackle the HER challenge, and we successfully demonstrated ultrahigh‐efficiency and long‐calendar‐life cadmium metal batteries under strict conditions (0.1 mA cm −2 , 99.75% efficiency, 21.4 months’ life). Even under extreme conditions, such as ultralow current (0.01 mA cm −2 ), long rest periods (up to 60 days), and wide temperature ranges (−50°C to +80°C), Cd maintains a high efficiency of 90%–99.9%. In stark contrast, zinc suffers from drastic performance degradation and loses 27%–73% efficiency. The superior performance is correlated with the distinct solvation structure in the concentrated electrolyte, which transforms the hydration form of Cd 2+ cations and strengthens water molecules via a strong cation‐coordination effect. Our work establishes a new benchmark for AMMBs and highlights the decisive role of electrode selection and electrolyte design in advancing AMMB performance.

A chance-constrained Bi-level scheduling framework for EV-integrated microgrids considering travel demand and uncertainty

Scientific Reports Xiaolong Zhang, Yifei Yin Jul 01, 2026 DOI: 10.1038/s41598-026-60220-7

Site‐Specific Carbazole‐Bridged Isomeric Guests Enable Organic Solar Cells with 21.10% Efficiency and Reduced Non‐Radiative Recombination

Advanced Materials Guangkuo Dai, Le Mei, Jiali Song et al. Jul 01, 2026 DOI: 10.1002/adma.73788

ABSTRACT Non‐radiative recombination losses in non‐fullerene acceptors (NFAs) represent a critical bottleneck limiting the open‐circuit voltage ( V oc ) and power conversion efficiency (PCE) of organic solar cells (OSCs). Herein, we report a molecular design strategy that harnesses luminescent‐carbazole linkage site isomerism to suppress non‐radiative recombination. Two carbazole‐functionalized NFAs, QxCz‑C and QxCz‑N, were designed and synthesized. Theoretical calculations reveal that QxCz‑C adopts a coplanar conformation, whereas the carbazole unit in QxCz‑N is oriented nearly perpendicular to the main chain. Upon incorporating QxCz‑C as a minor guest into the host material BTP‑eC9, a favorable mixed phase is formed, accompanied by efficient energy transfer from the guest to the host. The photoluminescence quantum yield of the blend acceptor is significantly enhanced, effectively suppressing electron‑phonon coupling, thereby reducing non‑radiative recombination loss and improving V oc . Simultaneously, guest incorporation optimizes molecular packing order and active layer morphology, facilitating exciton dissociation and charge transport. Consequently, the PM6:BTP‑eC9:QxCz‑C device achieves a PCE of 20.53%. The generality of this strategy is further validated in the D18:L8‑BO system, delivering an excellent PCE of 21.10%. This work establishes a quantitative “connectivity topology–molecular conformation–non‐radiative loss” structure–property relationship and provides a generalizable approach to overcoming the voltage bottleneck in OSCs.

Mechanically Programmable DNA Hydrogel Microparticles for 3D Cellular Systems

Advanced Materials Tobias Walther, Eleni Dalaka, Gotthold Fläschner et al. Jul 01, 2026 DOI: 10.1002/adma.202514218

ABSTRACT Hydrogel microparticles (HMPs) are powerful tools to study and manipulate cellular behavior in 3D cell culture systems and animal models. Here, fully DNA‐based HMPs are presented, whose material properties can be precisely tuned by sequence‐programmable design of self‐assembling DNA nanostructures. These DNA‐HMPs offer control over size, stiffness, viscoelasticity and ligand presentation. They are formed by microfluidic encapsulation of two types of orthogonal DNA nanostars and a sequence‐complementary DNA linker in water‐in‐oil droplets. By varying the valency of the DNA nanostar designs, tunable mechanical properties are achieved – spanning three orders of magnitude in Young's modulus from to with distinct viscoelastic behavior. Click‐chemistry based functionalization with the small fibronectin‐derived peptide cyclic‐RGD (c[RGD]) enables integration into fibroblast spheroids. DNA‐HMPs are stably retained within the spheroids for several days and undergo remodeling, indicating active interactions between the cells and the DNA‐HMPs. Combining programmable material properties and inherent biocompatibility of DNA with straightforward functionalization and stimuli‐responsiveness, these DNA‐HMPs represent a versatile tool to probe and manipulate tissue behaviors in 3D cell cultures.

Cryopreservative Bioink Enables Direct Bioprinting of Adherent Cells

Advanced Materials Xiyuan Zhao, Shenglong Ding, Dadi Sun et al. Jul 01, 2026 DOI: 10.1002/adma.72714

ABSTRACT Cryopreservation‐integrated bioprinting represents a promising approach for tissue regeneration by combining cell‐laden bioink freezing with direct post‐thaw printing, bypassing traditional culturing steps. However, key challenges remain: ice crystallization compromises cellular viability, while hydrogel structural integrity deteriorates, impairing printability. We present a biphasic bioink platform for cryopreservation‐enabled three‐dimensional (3D) bioprinting—CAMP (Cryopreservation for Adhesion and Maintenance Printing), which enables direct 3D printing at 4–8°C post liquid nitrogen storage (−196°C). CAMP inhibits ice recrystallization through hydrogen bond‐mediated water immobilization, achieving approximately 80% cell viability without the use of toxic cryoprotectants. Cryopreserved cells in the bioink retained focal adhesions and increased phosphorylated FAK expression, and the bioink exhibited approximately ten fold higher ice recrystallization inhibition than phosphate‐buffered saline. Mechanistically, CAMP suppressed cell death via phospho‐FAK signaling. In vivo evaluation using a rat femoral defect model demonstrated the therapeutic efficacy of CAMP, with cryopreserved constructs promoting complete bone regeneration within three months. CAMP overcomes the key limitations of conventional biofabrication by combining cell cryopreservation, bioprinting, and functional tissue formation into a single workflow. By bridging cryopreservation and bioprinting, CAMP represents a significant advance toward clinically viable, ready‐to‐implant engineered tissues.